ABIVAX Trademark

Trademark Overview

On Monday, May 9, 2022, a trademark application was filed for ABIVAX with the United States Patent and Trademark Office. The USPTO has given the ABIVAX trademark a serial number of 97400995. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, September 18, 2025. This trademark is owned by Abivax SA. The ABIVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of autoimmune, inflammatory, gastrointestinal disease; Pharmaceutical preparations for the prevention and treatment of oncologic, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, musculoskeletal, viral, and fungal disease; vaccines for human and veterinary use; adjuvants for use with vaccines
abivax

General Information

Serial Number97400995
Word MarkABIVAX
Filing DateMonday, May 9, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, September 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention of autoimmune, inflammatory, gastrointestinal disease; Pharmaceutical preparations for the prevention and treatment of oncologic, metabolic, rheumatic, dermatological, endocrine, ophthalmologic, neurologic, cardiovascular, musculoskeletal, viral, and fungal disease; vaccines for human and veterinary use; adjuvants for use with vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 13, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameABIVAX
Party Type21 - New Owner After Publication
Legal Entity Type33 - NOT AVAILABLE
AddressPARIS 75009
FR
Party NameAbivax SA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParis 75009
FR
Party NameAbivax SA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParis 75008
FR

Trademark Events

Event DateEvent Description
Thursday, May 12, 2022NEW APPLICATION ENTERED
Friday, May 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 27, 2023ASSIGNED TO EXAMINER
Monday, February 27, 2023NON-FINAL ACTION WRITTEN
Monday, February 27, 2023NON-FINAL ACTION E-MAILED
Monday, February 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 18, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, July 24, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Thursday, January 4, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, February 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 28, 2024NOTICE OF ALLOWANCE CANCELLED
Wednesday, February 28, 2024NEW NOA TO ISSUE
Wednesday, March 27, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 4, 2024SOU TEAS EXTENSION RECEIVED
Friday, October 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 4, 2024SOU EXTENSION 1 FILED
Friday, October 4, 2024SOU EXTENSION 1 GRANTED
Sunday, April 6, 2025SOU EXTENSION 2 FILED
Monday, April 7, 2025DIVISIONAL REQUEST RECEIVED
Monday, April 7, 2025SOU TEAS EXTENSION RECEIVED
Monday, April 7, 2025TEAS REQUEST TO DIVIDE RECEIVED
Thursday, September 18, 2025SOU EXTENSION 2 GRANTED
Thursday, September 18, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 18, 2025DIVISIONAL PROCESSING COMPLETE
Thursday, September 18, 2025CORRECTED NOA E-MAILED
Friday, September 19, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 22, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, September 22, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 22, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 22, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

abivax pharmaceutical vaccines disease preparations prevention musculoskeletal veterinary cardiovascular viral fungal